Khosla Lakshay, Boroda Joseph U, Salama Joshua, Rahman Syed N, Gordon Danielle J, Moy Matthew W, Akivis Yonatan, Akivis Alla, Lazar Jason M, Weiss Jeffrey P, Birder Lori A
Department of Urology, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Department of Urology, Yale School of Medicine, New Haven, CT, USA.
Int Neurourol J. 2022 Jun;26(2):135-143. doi: 10.5213/inj.2142330.165. Epub 2022 Jun 30.
The pathophysiology of nocturia and nocturnal polyuria (NP), conditions that become more prevalent with aging, may in part be explained by changes in hormones involved in water homeostasis. The purpose of this study was to analyze the impact of aging on urinary natriuretic peptides in nocturia and NP.
Patients aged ≥18 years completed 24-hour bladder diaries for assessment of nocturia and NP. They were divided into subgroups of ≥65 years old and <65 years old. Urine samples were collected and analyzed for natriuretic peptide (NT-proANP, NT-proBNP, and NT-proCNP) levels. Peptide levels were compared between patients with and without nocturia/NP and within age subgroups; correlation to the NP index (NPi) was determined.
Compared to patients without nocturia (N=15), patients with nocturia (N=36) had higher median levels of urinary NT-proANP (15.8 pmol/mmol Cr vs. 10.9 pmol/mmol Cr, P=0.016) and NT-proBNP (6.3 pmol/mmol Cr vs. 4.5 pmol/mmol Cr, P=0.021), but showed no differences in NT-proCNP (2.4 pmol/mmol Cr vs. 2.5 pmol/mmol Cr, P=0.967). Patients ≥65 years old with nocturia had higher NT-proANP (29.8 pmol/mmol Cr vs. 11.0 pmol/mmol Cr, P<0.001) and NT-proBNP (9.6 pmol/mmol Cr vs. 5.0 pmol/mmol Cr, P<0.001) than patients <65 years old. Additionally, patients with NP (N=30) showed higher urinary NT-proANP (19.6 pmol/mmol Cr vs. 10.5 pmol/mmol Cr, P<0.001) and NT-proBNP (6.7 pmol/mmol Cr vs. 4.7 pmol/mmol Cr, P=0.020) compared to patients without NP (N=21). NP patients ≥65 years had higher NT-proANP (29.8 pmol/mmol Cr vs. 12.5 pmol/mmol Cr, P<0.001) and NT-proBNP (9.6 pmol/mmol Cr vs. 4.4 pmol/mmol Cr, P=0.004) than patients <65 years old. NPi positively correlated with urinary NT-proANP (RS=0.417, P=0.002) and NT-proBNP (RS=0.303, P=0.031), but not with NT-proCNP (RS=-0.094, P=0.510).
Since urinary NT-proANP and NT-proBNP were greater in aged patients with nocturia and NP, natriuretic peptides may contribute to the pathophysiology of these conditions and further research should aim to explore them as targets for management.
夜尿症和夜间多尿(NP)的病理生理学在衰老过程中愈发普遍,其部分原因可能与水稳态相关激素的变化有关。本研究旨在分析衰老对夜尿症和NP患者尿钠肽的影响。
年龄≥18岁的患者完成24小时膀胱日记以评估夜尿症和NP。他们被分为≥65岁和<65岁两个亚组。收集尿液样本并分析尿钠肽(NT-proANP、NT-proBNP和NT-proCNP)水平。比较有和没有夜尿症/NP的患者之间以及年龄亚组内的肽水平;确定与NP指数(NPi)的相关性。
与无夜尿症患者(N = 15)相比,夜尿症患者(N = 36)的尿NT-proANP(15.8 pmol/mmol Cr对10.9 pmol/mmol Cr,P = 0.016)和NT-proBNP(6.3 pmol/mmol Cr对4.5 pmol/mmol Cr,P = 0.021)中位数水平更高,但NT-proCNP无差异(2.4 pmol/mmol Cr对2.5 pmol/mmol Cr,P = 0.967)。≥65岁的夜尿症患者比<65岁的患者有更高的NT-proANP(29.8 pmol/mmol Cr对11.0 pmol/mmol Cr,P<0.001)和NT-proBNP(9.6 pmol/mmol Cr对5.0 pmol/mmol Cr,P<0.001)。此外,与无NP患者(N = 21)相比,NP患者(N = 30)的尿NT-proANP(19.6 pmol/mmol Cr对10.5 pmol/mmol Cr,P<0.001)和NT-proBNP(6.7 pmol/mmol Cr对4.7 pmol/mmol Cr,P = 0.020)更高。≥65岁的NP患者比<65岁的患者有更高的NT-proANP(29.8 pmol/mmol Cr对12.5 pmol/mmol Cr,P<0.001)和NT-proBNP(9.6 pmol/mmol Cr对4.4 pmol/mmol Cr,P = 0.004)。NPi与尿NT-proANP(RS = 0.417,P = 0.002)和NT-proBNP(RS = 0.303,P = 0.031)呈正相关,但与NT-proCNP无相关性(RS = -0.094,P = 0.510)。
由于老年夜尿症和NP患者的尿NT-proANP和NT-proBNP更高,利钠肽可能在这些病症的病理生理学中起作用,进一步的研究应旨在探索将它们作为治疗靶点。